PayPoint on track in the third quarter

Payment systems operator PayPoint said that trading was in line with expectations in the third quarter, as a slowdown in revenue and transaction growth was the result of seasonality.

Payment systems operator PayPoint said that trading was in line with expectations in the third quarter, as a slowdown in revenue and transaction growth was the result of seasonality.

Transactions processed in the three months to December 31st totalled 193m, up 5% year-on-year. This compares with the 345m transactions processed in the first half, up 18%.

Meanwhile, revenues rose 4% to £55m during the period, down from the 6% growth in the first six months of the year.

Nevertheless, Chief Executive Dominic Taylor said: "Overall trading since September 30th 2012 was in line with market expectations, taking seasonality of trading into account.We are pleased with the growth across the group and continue to focus on driving improved returns on our invested capital."

Net revenues, which exclude retailer commission and the cost of mobile top-ups, gained £28.7m.

The firm saw strong growth in bill and general payments and retail services during the period, though this was partly offset by a decline in net revenue from mobile top-ups. Bill and general payment growth included set-up fees for the Simple Payment services for the Department for Work and Pensions which contributed six percentage points of the overall growth in net revenue.

Consumer parcel drop-off and collection service, CollectPlus, the company's joint venture with Yodel, saw volumes grow by 89% to 2.3m transactions during the period.

Meanwhile, internet transactions rose by 18% to 24m year-on-year.

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022